Rankings
▼
Calendar
BBOT Q4 2022 Earnings — BridgeBio Oncology Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BBOT
BridgeBio Oncology Therapeutics Inc.
$820M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3,520
Net Income
-$3,520
EPS (Diluted)
$-0.00
← FY 2022
All Quarters
FY 2023 →
